Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 52,707 | 57,206 | 74,519 | 110,115 | 126,280 |
| Cost of Goods | 9,504 | 49,188 | 24,756 | 20,538 | 11,700 |
| Gross Profit | 43,203 | 8,018 | 49,763 | 89,577 | 114,580 |
| Operating Expenses | 31,786 | 114,182 | 127,100 | 104,606 | 113,600 |
| Operating Income | 11,921 | -105,976 | -76,581 | -14,491 | 1,680 |
| Interest Expense | 9,582 | 9,547 | 9,348 | 8,615 | 3,991 |
| Other Income | -300 | 5,896 | 20,642 | 31,452 | 34,177 |
| Pre-tax Income | 2,039 | -109,627 | -65,287 | 8,346 | 31,866 |
| Income Tax | -16,838 | -19,001 | 2,105 | 4,001 | 4,717 |
| Net Income Continuous | 18,877 | -90,626 | -67,392 | 4,345 | 27,149 |
| Net Income Discontinuous | -224,949 | -14,515 | 20,853 | 661 | N/A |
| Minority Interests | -6 | -9 | 53 | -28 | -59 |
| Net Income | $-206,066 | $-105,132 | $-46,592 | $5,034 | $-5,321 |
| EPS Basic Total Ops | -3.08 | -1.57 | -0.71 | 0.08 | -0.08 |
| EPS Basic Continuous Ops | 0.28 | -1.35 | -1.02 | 0.07 | 0.42 |
| EPS Basic Discontinuous Ops | -3.36 | -0.22 | 0.31 | 0.01 | N/A |
| EPS Diluted Total Ops | -3.08 | -1.57 | -0.71 | 0.08 | -0.07 |
| EPS Diluted Continuous Ops | 0.28 | -1.35 | -1.02 | 0.07 | 0.42 |
| EPS Diluted Discontinuous Ops | -3.36 | -0.22 | 0.31 | 0.01 | N/A |
| EBITDA(a) | $28,722 | $-90,629 | $-63,293 | $-1,414 | $13,084 |